Contemporary medical therapy for polycystic ovary syndrome

Keyphrases

• Medical Therapy 100%
• Polycystic Ovary Syndrome 100%
• Treatment Options 50%
• Cardiovascular Health 50%
• Metabolic Health 50%
• Glucose-insulin System 50%
• Statins 50%
• Metformin 50%
• Medical Treatment 50%
• Oral Contraceptives 50%
• Infertility 50%
• Progestin 50%
• Pharmacotherapy 50%
• Insulin Sensitizers 50%
• Multisystem 50%
• Pioglitazone 50%
• Secondary Causes 50%
• Reductase 50%
• Ovulation Induction 50%
• Anovulation 50%
• Rosiglitazone 50%
• Hirsutism 50%
• Inter-patient Variability 50%
• Health Consequences 50%
• Thiazolidinediones 50%
• Androgen Excess 50%
• Hair Growth 50%
• Letrozole 50%
• Aromatase Inhibitors 50%
• Endocrinopathy 50%
• Follicle 50%
• Active Control 50%
• Antiandrogen 50%
• Aldosterone Antagonists 50%
• Hair Follicle 50%
• Hyperandrogenism 50%
• Management Options 50%
• Low Testosterone 50%
• Irregular Menstruation 50%
• Polycystic Ovary 50%
• Ornithine Decarboxylase Antizyme 50%
• CYP19 50%
• Actos 50%
• Oligo-anovulation 50%
• International Consensus Conference 50%
• Avandia 50%

Medicine and Dentistry

• Combination Therapy 100%
• Polycystic Ovary Syndrome 100%
• Pioglitazone 66%
• Rosiglitazone 66%
• Letrozole 66%
• Cardiovascular System 33%
• Drug Therapy 33%
• Follicle 33%
• Gestagen 33%
• Oxidoreductase 33%
• Glycon 33%
• Statin 33%
• Androgen 33%
• Oral Contraceptive Agent 33%
• Ovulation Induction 33%
• Anovulation 33%
• Endocrine Disease 33%
• Hirsutism 33%
• Thiazolidinedione 33%
• Aromatase Inhibitor 33%
• Aldosterone Antagonist 33%
• Hair Follicle 33%
• Hyperandrogenism 33%
• Menstrual Irregularity 33%
• Cytochrome P450 Family 19 33%
• Ornithine Decarboxylase Inhibitor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Ovary Polycystic Disease 100%
• Pioglitazone 66%
• Rosiglitazone 66%
• Letrozole 66%
• Progestin 33%
• Pharmacotherapy 33%
• Oxidoreductase 33%
• Oral Contraceptive Agent 33%
• Androgen 33%
• Endocrine Disease 33%
• Metformin 33%
• Thiazolidinedione 33%
• Aromatase Inhibitor 33%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 33%
• Aldosterone Antagonist 33%
• Anovulation 33%
• Hirsutism 33%
• Menstrual Irregularity 33%
• Ornithine Decarboxylase Inhibitor 33%
• Hyperandrogenism 33%
• Cytochrome P450 Family 19 33%